The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Financial toxicity and employment outcomes in people with melanoma receiving adjuvant therapies.
 
Julia Lai-Kwon
No Relationships to Disclose
 
Michael Jefford
No Relationships to Disclose
 
Ashkan Mehrnejad
No Relationships to Disclose
 
Mustafa Abdi Mohamed
No Relationships to Disclose
 
Kortnye Smith
No Relationships to Disclose
 
Lavinia Spain
Consulting or Advisory Role - Ipsen
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Iovance Biotherapeutics (Inst)
 
Aparna Rao
No Relationships to Disclose
 
Belinda Lee
Honoraria - Roche
Research Funding - AngioDynamics (Inst); Servier (Inst); Specialised Therapeutics (Inst)
Travel, Accommodations, Expenses - Ipsen; Roche
 
George Au-Yeung
Honoraria - Incyclix Bio
Consulting or Advisory Role - Incyclix Bio
Research Funding - AstraZeneca (Inst); Roche/Genentech (Inst)
 
Allison Drosdowsky
No Relationships to Disclose
 
Karla Gough
No Relationships to Disclose
 
Shahneen Sandhu
Honoraria - Abbvie (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Merck (Inst); Merck Serono (Inst); Novartis (Inst); Skyline Diagnostics (Inst)
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); Bristol Myers Squibb (Inst); Merck Sharp and Dohme (Inst); Novartis (Inst); Roche/Genentech (Inst); Skyline Diagnostics (Inst)
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Endocyte/Advanced Accelerator Applications (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Senhwa Biosciences (Inst)
(OPTIONAL) Uncompensated Relationships - AAA/Endocyte/Novartis (Inst)
 
ASCO Authors 2025
No Relationships to Disclose